Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of evolution of vaccination. We have Dr Srivastava and Dr Jaydeep Choudhury to lead the session.
It is well known to each one of us how the science of vaccine development has evolved starting from the invention of attenuated vaccines. We are also aware about the importance of vaccination for the children or neonates.
In this webinar, a more detailed discussion is provided on the development of 6-in-1 aP combination vaccine, its usage and its importance among the pediatric population.
The 6-in-1 aP combination vaccine is referred as DTaP/Hib/HepB/IPV, stands for 'Diphtheria, Tetanus, acellular Pertussis, Hib, Hepatitis B and Inactivated Polio Vaccine'. The advantage is one single vaccine can protect the child from the mentioned diseases and save the child from taking each of vaccines separately.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
Interleukin-6 may boost prediction of obesity-related cancers
2.
After all, Pulled Myeloma Drug May Help Treat the Illness.
3.
No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer
4.
Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care
5.
Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer
1.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
2.
Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends
3.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
4.
Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics
5.
Seeing the Difference: Using Ultrasound to Distinguish Fibroadenoma from Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
Navigating the Complexities of Ph Negative ALL - Part IX
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation